Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 205 of 1,261
  1. US 11602559

    HIV-1 Env fusion peptide immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  2. US 11602563

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  3. US 11603392

    Vault particles having a modified R8 flexible region

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  4. US 11603364

    Acyl hydrazone derivative compounds for treating disease

    Alterity Therapeutics Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  5. US 11603542

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  6. US 11602556

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  7. US 11603406

    Antibodies binding to VISTA at acidic pH

    Five Prime Therapeutics, Inc. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  8. US 11602551

    Use of inosine for the treatment of t-reg deficiency

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  9. CA 3230406

    UTILISATION DE MICRO-ARN POUR LA REGULATION NEGATIVE DE L'EXPRESSION DE TRANSGENES CYTOTOXIQUES PAR LE VIRUS DE LA VACCINE ANKARA MODIFIE (MVA)

    BAVARIAN NORDIC AS [DK] · Granted Mar 9, 2023 · Expires Mar 4, 2043

    granted
  10. US 11597928

    Nucleic acid complex

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  11. US 11597748

    Peptide having cytoprotective effect against environmental pollutant and use thereof

    CAREGEN CO., LTD. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  12. US 11596635

    Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  13. US 11597853

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  14. US 11597916

    Nicotine degrading enzyme variants

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  15. US 11598015

    Fabrication of dendritic structures and tags

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  16. US 11597924

    Genome editing systems comprising repair-modulating enzyme molecules and methods of their use

    Editas Medicine, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  17. US 11597948

    Use of ANP32 protein in maintaining the polymerase activity of influenza virus in hosts

    Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences (China Animal Health and Epidemiology Center Harbin Branch Center) · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  18. US 11597749

    Peptide compositions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  19. US 11596909

    System and method for droplet formation and manipulation using ferrofluids

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  20. US 11597773

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  21. US 11597727

    Inhibitors of integrin alpha 2 beta 1 and methods of use

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  22. US 11596694

    Compositions and methods for predicting response to NaPi2b-targeted therapy

    Mersana Therapeutics, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  23. US 11596711

    Solubilization of antigen components for removal from tissues

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  24. US 11597765

    Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

    VACCINEX, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.